Kinarus Therapeutics Phase 2 KINFAST Covid-19 Clinical
KINFAST is evaluating KIN001 for reduction in severity and duration of Covid-19 symptomsKINFAST is actively enrolling
Globe Newswire21-02-2023, 13:07
Culture Summit Abu Dhabi 2023 to Convene Global Thought Leaders to Reflect on the Theme ‘A Matter of Time’ 3-10-2023, 15:48